Type I interferon-associated cytotoxic inflammation in cutaneous lupus erythematosus

Archives of Dermatological Research

Volumn 301, Issue 1, 2009, Pages 83-86

  Wenzel, Joerg ^a   Zahn, Sabine ^a   Bieber, Thomas ^a   Tüting, Thomas ^a  

^a UNIVERSITY OF BONN   (Germany)

Author keywords

CXCL10; CXCL9; CXCR3; Lupus; Skin

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CYTOKINE; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON; MYXOVIRUS RESISTANCE PROTEIN A; RECOMBINANT ALPHA INTERFERON;

ANTIGEN PRESENTING CELL; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DISEASE ACTIVITY; DISEASE SEVERITY; HISTOPATHOLOGY; HUMAN; INNATE IMMUNITY; LUPUS ERYTHEMATOSUS; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; SKIN LUPUS ERYTHEMATOSUS; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; CHEMOKINES; CYTOTOXICITY, IMMUNOLOGIC; HOMEOSTASIS; HUMANS; IMMUNITY, INNATE; INFLAMMATION; INTERFERON TYPE I; LUPUS ERYTHEMATOSUS, CUTANEOUS; LUPUS ERYTHEMATOSUS, SYSTEMIC; T-LYMPHOCYTES, CYTOTOXIC; TOLL-LIKE RECEPTORS;

EID: 58149161860     PISSN: 03403696     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00403-008-0892-8     Document Type: Review

References (39)

1. C Adam Y Thoua P Ronco 1980 The effect of exogenous interferon: acceleration of autoimmune and renal diseases in (NZB/W) F1 mice Clin Exp Immunol 40 373 382
2. I Arrue A Saiz PL Ortiz-Romero 2007 Lupus-like reaction to interferon at the injection site: report of five cases J Cutan Pathol 34 Suppl 1 18 21 10.1111/j.1600-0560.2007.00715.x
3. C Asselin-Paturel G Brizard K Chemin 2005 Type I interferon dependence of plasmacytoid dendritic cell activation and migration J Exp Med 201 1157 1167 10.1084/jem.20041930
4. EC Baechler FM Batliwalla G Karypis 2003 Interferon-inducible gene expression signature in peripheral blood cells of patients with severe lupus Proc Natl Acad Sci USA 100 2610 2615 10.1073/pnas.0337679100
5. L Bennett AK Palucka E Arce 2003 Interferon and granulopoiesis signatures in systemic lupus erythematosus blood J Exp Med 197 711 723 10.1084/jem.20021553
6. S Blomberg ML Eloranta B Cederblad 2001 Presence of cutaneous interferon-alpha producing cells in patients with systemic lupus erythematosus Lupus 10 484 490 10.1191/096120301678416042
7. D Braun P Geraldes J Demengeot 2003 Type I Interferon controls the onset and severity of autoimmune manifestations in lpr mice J Autoimmun 20 15 25 10.1016/S0896-8411(02)00109-9
8. I Clark-Lewis I Mattioli JH Gong 2003 Structure-function relationship between the human chemokine receptor CXCR3 and its ligands J Biol Chem 278 289 295 10.1074/jbc.M209470200
9. N Costedoat-Chalumeau Z Amoura JS Hulot 2006 Low blood concentration of hydroxychloroquine is a marker for and predictor of disease exacerbations in patients with systemic lupus erythematosus Arthritis Rheum 54 3284 3290 10.1002/art.22156
10. MC Dall'era PM Cardarelli BT Preston 2005 Type I interferon correlates with serological and clinical manifestations of SLE Ann Rheum Dis 64 1692 1697 10.1136/ard.2004.033753
11. J Fah J Pavlovic G Burg 1995 Expression of MxA protein in inflammatory dermatoses J Histochem Cytochem 43 47 52
12. L Farkas K Beiske F Lund-Johansen 2001 Plasmacytoid dendritic cells (natural interferon-alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions Am J Pathol 159 237 243
13. RR Graham SV Kozyrev EC Baechler 2006 A common haplotype of interferon regulatory factor 5 (IRF5) regulates splicing and expression and is associated with increased risk of systemic lupus erythematosus Nat Genet 38 550 555 10.1038/ng1782
14. B Guillot P Portales A Du Thanh 2005 The expression of cytotoxic mediators is altered in mononuclear cells of patients with melanoma and increased by interferon-alpha treatment Br J Dermatol 152 690 696 10.1111/j.1365-2133.2005.06512.x
15. K Hasegawa T Hayashi 2003 Synthetic CpG oligodeoxynucleotides accelerate the development of lupus nephritis during preactive phase in NZB x NZWF1 mice Lupus 12 838 845 10.1191/0961203303lu483oa
16. JJ Hooks HM Moutsopoulos SA Geis 1979 Immune interferon in the circulation of patients with autoimmune disease N Engl J Med 301 5 8
17. W Iijima H Ohtani T Nakayama 2003 Infiltrating CD8+ T cells in oral lichen planus predominantly express CCR5 and CXCR3 and carry respective chemokine ligands RANTES/CCL5 and IP-10/CXCL10 in their cytolytic granules: a potential self-recruiting mechanism Am J Pathol 163 261 268
18. A Kuhn M Herrmann S Kleber 2006 Accumulation of apoptotic cells in the epidermis of patients with cutaneous lupus erythematosus after ultraviolet irradiation Arthritis Rheum 54 939 950 10.1002/art.21658
19. A Kuhn M Sonntag P Lehmann 2002 Characterization of the inflammatory infiltrate and expression of endothelial cell adhesion molecules in lupus erythematosus tumidus Arch Dermatol Res 294 6 13 10.1007/s00403-001-0286-7
20. A Kuhn M Sonntag C Sunderkotter 2002 Upregulation of epidermal surface molecule expression in primary and ultraviolet-induced lesions of lupus erythematosus tumidus Br J Dermatol 146 801 809 10.1046/j.1365-2133.2002.04693.x
21. T Lovgren ML Eloranta U Bave 2004 Induction of interferon-alpha production in plasmacytoid dendritic cells by immune complexes containing nucleic acid released by necrotic or late apoptotic cells and lupus IgG Arthritis Rheum 50 1861 1872 10.1002/art.20254
22. T Lovgren ML Eloranta B Kastner 2006 Induction of interferon-alpha by immune complexes or liposomes containing systemic lupus erythematosus autoantigen- and Sjogren's syndrome autoantigen-associated RNA Arthritis Rheum 54 1917 1927 10.1002/art.21893
23. S Meller F Winterberg M Gilliet 2005 Ultraviolet radiation-induced injury, chemokines, and leukocyte recruitment: an amplification cycle triggering cutaneous lupus erythematosus Arthritis Rheum 52 1504 1516 10.1002/art.21034
24. LE Munoz US Gaipl S Franz 2005 SLE-a disease of clearance deficiency? Rheumatology (Oxford) 44 1101 1107 10.1093/rheumatology/keh693
25. F Nyberg T Hasan C Skoglund 1999 Early events in ultraviolet light-induced skin lesions in lupus erythematosus: expression patterns of adhesion molecules ICAM-1, VCAM-1 and E-selectin Acta Derm Venereol 79 431 436 10.1080/000155599750009852
26. F Nyberg E Stephansson 1999 Elevated soluble E-selectin in cutaneous lupus erythematosus Adv Exp Med Biol 455 153 159
27. A Rahman DA Isenberg 2008 Systemic lupus erythematosus N Engl J Med 358 929 939 10.1056/NEJMra071297
28. L Ronnblom ML Eloranta GV Alm 2006 The type I interferon system in systemic lupus erythematosus Arthritis Rheum 54 408 420 10.1002/art.21571
29. ML Santiago-Raber R Baccala KM Haraldsson 2003 Type-I interferon receptor deficiency reduces lupus-like disease in NZB mice J Exp Med 197 777 788 10.1084/jem.20021996
30. MJ Smit P Verdijk EM van der Raaij-Helmer 2003 CXCR3-mediated chemotaxis of human T cells is regulated by a Gi- and phospholipase C-dependent pathway and not via activation of MEK/p44/p42 MAPK nor Akt/PI-3 kinase Blood 102 1959 1965 10.1182/blood-2002-12-3945
31. RD Sontheimer JR Thomas JN Gilliam 1979 Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset Arch Dermatol 115 1409 1415 10.1001/archderm.115.12.1409
32. B Tebbe L Mazur R Stadler 1995 Immunohistochemical analysis of chronic discoid and subacute cutaneous lupus erythematosus-relation to immunopathological mechanisms Br J Dermatol 132 25 31 10.1111/j.1365-2133.1995. tb08620.x
33. J Wenzel S Henze S Brahler 2005 The expression of human leukocyte antigen-DR and CD25 on circulating T cells in cutaneous lupus erythematosus and correlation with disease activity Exp Dermatol 14 454 459 10.1111/j.0906-6705. 2005.00301.x
34. J Wenzel S Henze E Wörrenkämper 2005 Role of the chemokine receptor CCR4 and its ligand TARC/CCL17 for lymphocyte recruitment in cutaneous lupus erythematosus J Invest Dermatol 124 1241 1248 10.1111/j.0022-202X.2005. 23755.x
35. Wenzel J, Tuting T (2008) An IFN-associated cytotoxic cellular immune response against viral, self-, or tumor antigens is a common pathogenetic feature in "interface dermatitis". J Invest Dermatol (in press), 17 April 2008 [Epub ahead of print]
36. J Wenzel T Tuting 2007 Identification of type I interferon-associated inflammation in the pathogenesis of cutaneous lupus erythematosus opens up options for novel therapeutic approaches Exp Dermatol 16 454 463 10.1111/j.1600-0625.2007.00556.x
37. J Wenzel M Uerlich E Worrenkamper 2005 Scarring skin lesions of discoid lupus erythematosus are characterized by high numbers of skin-homing cytotoxic lymphocytes associated with strong expression of the type I interferon-induced protein MxA Br J Dermatol 153 1011 1015 10.1111/j.1365-2133.2005.06784.x
38. J Wenzel E Worenkamper S Freutel 2005 Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus J Pathol 205 435 442 10.1002/path.1721
39. J Wenzel S Zahn S Mikus 2007 The expression pattern of interferon-inducible proteins reflects the characteristic histological distribution of infiltrating immune cells in different cutaneous lupus erythematosus subsets Br J Dermatol 157 752 757 10.1111/j.1365-2133.2007.08137.x